Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Jayadev Manikkam Umakanthan; Mathew A. Lunning

doi:10.1016/j.beha.2017.10.004

Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Jayadev Manikkam Umakanthan, Mathew A. Lunning

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

Original language	English (US)
Pages (from-to)	23-30
Number of pages	8
Journal	Best Practice and Research: Clinical Haematology
Volume	31
Issue number	1
DOIs	https://doi.org/10.1016/j.beha.2017.10.004
State	Published - Mar 2018

Keywords

Advanced stage
Follicular Lymphoma
Treatment

ASJC Scopus subject areas

Oncology
Clinical Biochemistry

Access to Document

10.1016/j.beha.2017.10.004

Cite this

@article{45fbda3ab94f4bb9957649443d43ab94,

title = "Management of untreated advanced stage follicular lymphoma: Role of patient discernment",

abstract = "Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.",

keywords = "Advanced stage, Follicular Lymphoma, Treatment",

author = "Umakanthan, {Jayadev Manikkam} and Lunning, {Mathew A.}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",

year = "2018",

month = mar,

doi = "10.1016/j.beha.2017.10.004",

language = "English (US)",

volume = "31",

pages = "23--30",

journal = "Best Practice and Research: Clinical Haematology",

issn = "1521-6926",

publisher = "Bailliere Tindall Ltd",

number = "1",

}

TY - JOUR

T1 - Management of untreated advanced stage follicular lymphoma

T2 - Role of patient discernment

AU - Umakanthan, Jayadev Manikkam

AU - Lunning, Mathew A.

PY - 2018/3

Y1 - 2018/3

N2 - Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

AB - Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.

KW - Advanced stage

KW - Follicular Lymphoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85034454413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034454413&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2017.10.004

DO - 10.1016/j.beha.2017.10.004

M3 - Review article

C2 - 29452663

AN - SCOPUS:85034454413

SN - 1521-6926

VL - 31

SP - 23

EP - 30

JO - Best Practice and Research: Clinical Haematology

JF - Best Practice and Research: Clinical Haematology

IS - 1

ER -

Management of untreated advanced stage follicular lymphoma: Role of patient discernment

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this